VIRDANTE PHARMACEUTICALS

Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company was founded in 2007 and is based in Cambridge, Massachusetts.
VIRDANTE PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.virdante.com
Total Employee:
11+
Status:
Active
Contact:
617-300-8500
Email Addresses:
[email protected]
Total Funding:
60.08 M USD
Technology used in webpage:
Amazon
Similar Organizations
Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Cerium Pharmaceuticals
Cerium Pharmaceuticals is a biopharmaceutical company that commercializes and develops medicines for rare and ultra-rare diseases.
Fabre-Kramer Pharmaceuticals
Fabre-Kramer Pharmaceuticals was formed to identify, develop and commercialize psychotropic drugs with significant market potential.
Gordagen Pharmaceuticals
Gordagen Pharmaceuticals is a private Australian company, developing novel treatments for hyperlipidaemia, diabetes, inflammatory diseases
Keel Pharmaceuticals
Keel Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat type 1 diabetes and other autoimmune diseases.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venrock
Venrock investment in Series A - Virdante Pharmaceuticals
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series A - Virdante Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Virdante Pharmaceuticals
Biogen
Biogen investment in Series A - Virdante Pharmaceuticals
Clarus Ventures
Clarus Ventures investment in Series A - Virdante Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Series A - Virdante Pharmaceuticals
Official Site Inspections
http://www.virdante.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Virdante Pharmaceuticals"
Virdante Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Virdante Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Virdante Pharmaceuticals is a …See details»
Virdante Pharmaceuticals Company Profile | Management and
Virdante's leadership team comprises management, board members, and advisors with significant experience building and operating successful biopharmaceutical businesses. The leadership …See details»
Virdante Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Virdante Pharmaceuticals, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Virdante Pharmaceuticals - LinkedIn
Virdante Pharmaceuticals | 1,807 followers on LinkedIn. Virdante is a privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and ...See details»
Virdante Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 21, 2025 Virdante Pharmaceuticals is a series B company based in Cambridge (United States), founded in 2007. It operates as an Antibodies to treat inflammatory and autoimmune …See details»
Virdante Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 101 Main Street Suite 1210. Cambridge, Massachusetts, 02142, United States. 617-300-8500See details»
Virdante Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Virdante Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Virdante Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Oct 14, 2011: Venture Round - Virdante Pharmaceuticals — obfuscated. …See details»
Virdante Pharmaceuticals - Ownership and Business Overview
Virdante Pharmaceuticals was founded in 2007. Life Science M&A Summary in . Join Mergr to view all 0 acquisitions of life science companies in , including . Virdante Pharmaceuticals, Inc. …See details»
Virdante Pharmaceuticals - VentureRadar
Virdante`s leadership team comprises management, board members, investors and advisors with significant experience building and operating successful biopharmaceutical businesses. The …See details»
Virdante Pharmaceuticals (Sialic Switch Assets) - PitchBook
Dec 5, 2011 Information on acquisition, funding, cap tables, investors, and executives for Virdante Pharmaceuticals (Sialic Switch Assets). Use the PitchBook Platform to explore the …See details»
Virdante Pharmaceuticals Inc.
Virdante Pharmaceuticals aims to improve the anti-inflammatory properties of antibodies with proprietary "sialic switch" technology developed by scientific founder Jeffrey Ravetch, MD, …See details»
Virdante Pharmaceuticals - PitchBook
Virdante Pharmaceuticals was acquired on 05-Dec-2011. Who acquired Virdante Pharmaceuticals? Virdante Pharmaceuticals was acquired by Momenta Pharmaceuticals. …See details»
Virdante Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: virdante.com : Virdante Pharmaceuti... industries Biotech: Virdante Pharmaceuti... Employees Size 10-50 employees: Virdante Pharmaceuticals headquarters is …See details»
Virdante Pharmaceuticals - Overview, News & Competitors
Virdante's leadership team comprises management, board members, and advisors with significant experience building and operating successful biopharmaceutical businesses. The leadership …See details»
Virdante Pharma Raises $47 Million - venturecapitaljournal.com
Oct 29, 2009 Virdante Pharmaceuticals, a Cambridge, Mass.-based developer of technology to increase the anti-inflammatory potency of plasma-derived intravenous immune globulin, has …See details»
Virdante Pharmaceuticals - Updates, News, Events, Signals
Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Momenta Buys Assets From Virdante for Up to $51.5 Million
Virdante, a venture-backed biotechnology company, was founded in 2008 to apply its Sialic Switch technology to develop novel therapeutic treatments for autoimmune and inflammatory …See details»
Verdant Charity - Facilitating Instant International Donations
Verdant Charity facilitates instant international donation transfers, making it easier and faster to support global communities. Host donation links and contribute to positive, lasting change by …See details»
Virdante Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Virdante Pharmaceuticals uses 12 technology products and services including HTML5, Cloudflare CDN, and Apache Server, according to G2 Stack. Virdante Pharmaceuticals is actively using 2 …See details»